Literature DB >> 16328928

Pattern VEP alterations in psoriatic patients may indicate a sub clinic optic neuritis.

M Perossini1, E Turio, T Perossini, M Romagnoli, S Benedetti, G Cei, P Barachini, M Nardi.   

Abstract

We examined 44 subject (Group A) of both sexes (27 males and 17 females) aging between 16 and 80 (average: 45+/-16.6), divided into age bands, affected by mild-medium psoriasis with PASI (psoriasis area and severity index) between 1.2 and 48.6 (average: 11.2+/-9.7) without any other disease and we performed pattern transient VEP (Visual Evoked Potential) at the frequencies usually used in clinical experience (73', 36', 18' check size). For a good statistic comparison we choose 55 healthy subjects (group B) divided into age bands on which we performed the same test. Comparison of VEP parameters between psoriatic and healthy subjects, showed in group A 10 normal (22.7%) and 34 pathological (77.3%). In the latter group there are 16 subjects who show only a P100 reduced amplitude (36.3%), 3 with only increased latency (6.8%), 15 with alterations of both values (34%). The achieved data show that more than 3/4 of group A subjects have VEP alterations as index of the presence of a sub clinic optic neuritis with a probably toxic autoimmune origin due to the action of TNFalpha, of IgG, of ECP or of other cytokines (IL6, IL7, etc) that are increased in the blood of this patients. The electro physiologic monitoring of optic nerve seems to represent a good routine test to evaluate the global conditions of psoriatic patients.

Entities:  

Mesh:

Year:  2005        PMID: 16328928     DOI: 10.1007/s10633-005-4830-1

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  27 in total

1.  Immunologic targets in psoriasis.

Authors:  Thomas S Kupper
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

Review 2.  Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.

Authors:  Brian J Nickoloff; Frank O Nestle
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 3.  Assessment of disease progress in psoriasis.

Authors:  R Marks; S P Barton; D Shuttleworth; A Y Finlay
Journal:  Arch Dermatol       Date:  1989-02

4.  Stress, symmetry, and psoriasis: possible role of neuropeptides.

Authors:  E M Farber; B J Nickoloff; B Recht; J E Fraki
Journal:  J Am Acad Dermatol       Date:  1986-02       Impact factor: 11.527

5.  Plasma concentrations of IFN-gamma and TNF-alpha in psoriatic patients before and after local treatment with dithranol ointment.

Authors:  G Chodorowska
Journal:  J Eur Acad Dermatol Venereol       Date:  1998-03       Impact factor: 6.166

6.  Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy.

Authors:  S Iyer; P Yamauchi; N J Lowe
Journal:  Br J Dermatol       Date:  2002-01       Impact factor: 9.302

7.  The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions.

Authors:  M S Al'Abadie; G G Kent; D J Gawkrodger
Journal:  Br J Dermatol       Date:  1994-02       Impact factor: 9.302

8.  Activity of Tumor Necrosis Factor-alfa (TNF-alpha) and selected acute phase proteins in plasma of psoriatic patients receiving local treatment.

Authors:  G Chodorowska; M Juszkiewicz-Borowiec; D Czelej; D Wojnowska; M Kowal
Journal:  Ann Univ Mariae Curie Sklodowska Med       Date:  2001

9.  The pathophysiological role of cytokines in psoriasis.

Authors:  K Asadullah; W D Döcke; H D Volk; W Sterry
Journal:  Drugs Today (Barc)       Date:  1999-12       Impact factor: 2.245

10.  A randomized trial of etanercept as monotherapy for psoriasis.

Authors:  Alice B Gottlieb; Robert T Matheson; Nicholas Lowe; Gerald G Krueger; Sewon Kang; Bernard S Goffe; Anthony A Gaspari; Mark Ling; Gerald D Weinstein; Anjuli Nayak; Kenneth B Gordon; Ralph Zitnik
Journal:  Arch Dermatol       Date:  2003-12
View more
  2 in total

1.  Pattern VEPs before and after idiopathic epiretinal membrane removal.

Authors:  Masahiro Suami; Atsushi Mizota; Yoshihiro Hotta; Minoru Tanaka
Journal:  Doc Ophthalmol       Date:  2007-01-11       Impact factor: 2.379

2.  Relationship between retinal sensitivity and disease activity in patients with psoriasis vulgaris.

Authors:  Helin Deniz Demir; Göknur Kalkan; Semiha Kurt; Alper Güneş; Engin Sezer; Ünal Erkorkmaz
Journal:  Clinics (Sao Paulo)       Date:  2015-01       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.